FDA Approved: POSACONAZOLE — Original Application (NorthStar RxLLC)

View source ↗

Summary

The FDA approved NorthStar RxLLC's original application for posaconazole, granting authorization for a generic posaconazole product (ANDA 214321).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidiasis
• Invasive Aspergillosis
• Oropharyngeal Candidiasis

Drugs mentioned

• POSACONAZOLE (POSACONAZOLE)

Snippet

ORIG AP for POSACONAZOLE (POSACONAZOLE)